What Do Tesla Delivery Numbers Mean for Tesla Stock?
Tesla (NASDAQ:TSLA) released Q1 delivery numbers, showing a substantial slowdown…
Buy
58
BRO Quote, Financials, Valuation and Earnings
Last price:
$118.77
Seasonality move
:
5.77%
Day range:
$115.74 - $118.91
52-week range:
$80.33 - $125.68
Dividend yield:
0.47%
P/E ratio:
34.35x
P/S ratio:
7.24x
P/B ratio:
5.29x
Volume:
2M
Avg. volume:
2.1M
1-year change:
43.81%
Market cap:
$34B
Revenue:
$4.7B
EPS (TTM):
$3.46
Analysts' Opinion
-
Consensus RatingBrown & Brown has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 7 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $117.59, Brown & Brown has an estimated downside of -1.07% from its current price of $118.86.
-
Price Target UpsideAccording to analysts, the highest upside price target is $126.00 representing 6.01% upside increase from its current price of $118.86.
Fair Value
-
According to the consensus of 10 analysts, Brown & Brown has -1.07% downside to fair value with a price target of $117.59 per share.
BRO vs. S&P 500
-
Over the past 5 trading days, Brown & Brown has underperformed the S&P 500 by -2.23% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Brown & Brown does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Brown & Brown has grown year-over-year revenues for 58 quarters straight. In the most recent quarter Brown & Brown reported revenues of $1.1B.
Earnings Growth
-
Brown & Brown earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Brown & Brown reported earnings per share of $0.73.
Enterprise value:
37.1B
EV / Invested capital:
--
Price / LTM sales:
7.24x
EV / EBIT:
24.63x
EV / Revenue:
7.96x
PEG ratio (5yr expected):
2.63x
EV / Free cash flow:
34.01x
Price / Operating cash flow:
30.94x
Enterprise value / EBITDA:
21.44x
Gross Profit (TTM):
$2.3B
Return On Assets:
6.15%
Net Income Margin (TTM):
21.3%
Return On Equity:
16.39%
Return On Invested Capital:
10.03%
Operating Margin:
21.76%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $3.6B | $4.2B | $4.7B | $972M | $1.1B | |
| Gross Profit | $1.7B | $2B | $2.3B | $418M | $506M | |
| Operating Income | $962.9M | $1.1B | $1.3B | $205M | $237M | |
| EBITDA | $1.2B | $1.6B | $1.7B | $462M | $387M | |
| Diluted EPS | $2.36 | $3.06 | $3.46 | $0.94 | $0.73 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3B | $3.3B | $5B | $5.1B | $6.9B | |
| Total Assets | $9B | $9.8B | $14B | $14.9B | $17.6B | |
| Current Liabilities | $2.4B | $2.7B | $4.6B | $5B | $6.3B | |
| Total Liabilities | $5.2B | $5.6B | $9.4B | $9.3B | $11.2B | |
| Total Equity | $3.8B | $4.2B | $4.6B | $5.6B | $6.4B | |
| Total Debt | $2.1B | $2B | $3.9B | $3.8B | $3.8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $881M | $1B | $1.2B | $306M | $361M | |
| Cash From Investing | -$1.9B | -$587M | -$898M | -$394M | -$779M | |
| Cash From Financing | $1.7B | -$187M | -$64M | $88M | $277M | |
| Free Cash Flow | $829M | $941M | $1.1B | $275M | $341M | |
BRO
Sector
Market Cap
$34B
$564.4M
Price % of 52-Week High
94.58%
78.9%
Dividend Yield
0.47%
2.15%
Shareholder Yield
0.64%
3.67%
1-Year Price Total Return
43.81%
2.51%
Beta (5-Year)
0.750
0.555
Dividend yield:
0.47%
Annualized payout:
$0.54
Payout ratio:
15.49%
Growth streak:
31 years
Technicals
8-day SMA
Buy
Level
$117.69
200-day SMA
Buy
Level
$106.05
Bollinger Bands (100)
Buy
Level
103.94 - 117.62
Chaikin Money Flow
Buy
Level
291.3M
20-day SMA
Sell
Level
$119.87
Relative Strength Index (RSI14)
Buy
Level
51.67
ADX Line
Sell
Level
31.33
Williams %R
Neutral
Level
-41.9256
50-day SMA
Buy
Level
$115.65
MACD (12, 26)
Buy
Level
0.15
25-day Aroon Oscillator
Sell
Level
-16
On Balance Volume
Neutral
Level
207.9M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.644)
Sell
CA Score
(Annual)
Level (-0.535)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.1322)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Brown & Brown Inc is a diversified insurance agency, wholesale brokerage, insurance programs, and service. The Company markets and sells insurance products and services, in the property, casualty, and employee benefits areas. It provides customers with non-investment insurance contracts, as well as other targeted, customized risk management products and services. It has four reportable segments; the Retail segment; the Programs segment; the Wholesale Brokerage segment and; the Services segment. It generates the majority of its revenue from the Retail segment which provides insurance products and services to commercial, public and quasi-public, and Others through automobile dealer services F&I businesses. Its geographic area is U.S., U.K., the Republic of Ireland, Canada, and Others.
Stock Forecast FAQ
In the current month, BRO has received 3 Buy ratings 7 Hold ratings, and 0 Sell ratings. The BRO average analyst price target in the past 3 months is $117.59.
-
Where Will Brown & Brown Stock Be In 1 Year?
According to analysts, the consensus estimate is that Brown & Brown share price will drop to $117.59 per share over the next 12 months.
-
What Do Analysts Say About Brown & Brown?
Analysts are divided on their view about Brown & Brown share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Brown & Brown is a Sell and believe this share price will rise from its current level to $102.00.
-
What Is Brown & Brown's Price Target?
The price target for Brown & Brown over the next 1-year time period is forecast to be $117.59 according to 10 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is BRO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Brown & Brown is a Hold. 7 of 10 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of BRO?
You can purchase shares of Brown & Brown via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Brown & Brown shares.
-
What Is The Brown & Brown Share Price Today?
Brown & Brown was last trading at $118.77 per share. This represents the most recent stock quote for Brown & Brown. Yesterday, Brown & Brown closed at $118.86 per share.
-
How To Buy Brown & Brown Stock Online?
In order to purchase Brown & Brown stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Chewy a Growth Stock to Buy?
It might be a surprise to learn that during the…
Is Realty Income the Best Dividend Stock to Buy Long-Term?
Realty Income (NYSE:O) is a longstanding real estate investment trust…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Sell
42
KMX alert for Apr 12
CarMax [KMX] is up 2.87% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
Sell
30
CRSP alert for Apr 12
CRISPR Therapeutics AG [CRSP] is up 14.59% over the past day.
